SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-057180
Filing Date
2024-05-09
Accepted
2024-05-09 16:45:59
Documents
56
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q etnb-20240331.htm   iXBRL 10-Q 1472970
2 EX-31.1 etnb-ex31_1.htm EX-31.1 14332
3 EX-31.2 etnb-ex31_2.htm EX-31.2 14344
4 EX-32 etnb-ex32.htm EX-32 14906
  Complete submission text file 0000950170-24-057180.txt   6923856

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT etnb-20240331.xsd EX-101.SCH 1227763
60 EXTRACTED XBRL INSTANCE DOCUMENT etnb-20240331_htm.xml XML 1130986
Mailing Address 142 SANSOME STREET SECOND FLOOR SAN FRANCISCO CA 94104
Business Address 142 SANSOME STREET SECOND FLOOR SAN FRANCISCO CA 94104 (415) 432-9270
89bio, Inc. (Filer) CIK: 0001785173 (see all company filings)

IRS No.: 831114349 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39122 | Film No.: 24931506
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)